Subcutaneous vs intramuscular injections: the differences

A subcutaneous (subQ) injection goes into the fat layer just under the skin using a short needle, while an intramuscular (IM) injection goes deeper, into muscle, using a longer needle. Muscle has a richer blood supply, so IM medicines generally reach the bloodstream faster. The route isn’t interchangeable or a matter of preference: it’s part of your prescription and the product’s label. For subQ medicines measured with an insulin syringe, the syringe reader shows where your draw sits on the barrel.

At a glance

Sources: MedlinePlus subQ, MedlinePlus IM, the CDC’s vaccine administration guidance for needle lengths and gauges, Frid et al., 2016 for insulin needles, and Erstad and Barletta, 2022 for absorption.

How deep is each layer?

An ultrasound study of 388 adults found the skin is only about 2 mm thick at the usual injection sites, with the fat layer underneath averaging roughly 10 to 15 mm (Gibney et al., 2010). That’s why short needles work for subQ: a 4 or 6 mm needle gets through the skin and stops in the fat. International injection recommendations call the 4 mm pen needle and 6 mm syringe needle the first choice for insulin, and say intramuscular injections of insulin should be avoided because they can cause severe low blood sugar (Frid et al., 2016). That’s a concrete example of why the route matters.

IM needles have to pass through the fat and into the muscle, so they’re much longer. The CDC’s adult guidance for IM vaccines uses 1 to 1.5 inch needles depending on body weight (CDC).

Why absorption differs

StatPearls explains that large muscles have a rich blood supply, so a drug injected into them reaches the bloodstream quickly (StatPearls). A pharmacy review in the American Journal of Health-System Pharmacy puts it in practical terms: subQ is preferred for products like insulin, where “a slower and more sustained response is desirable”, and IM for products like vaccines, where more rapid absorption is wanted (Erstad and Barletta, 2022). The same review notes that an IM medicine can end up in the fat by mistake if the needle is too short. The route is built into how a medicine is designed and dosed, so a product made for one route can behave differently if it’s given by the other.

IM sites need more care

MedlinePlus describes four IM sites (the middle of the thigh, the hip, the upper arm and the upper outer buttock) and warns that the buttock site must be measured carefully, “because an injection given in the wrong place could hit a nerve or blood vessel” (MedlinePlus). It also advises showing your health care provider how you’ll choose the spot before you inject at home. The AJHP review lists sciatic nerve injury as a risk, particularly with IM injection into the upper outer buttock. SubQ sites are more forgiving, which is one reason most self-injected medicines are given subQ.

The math is the same

The route doesn’t change the vial math. Volume is volume:

• 0.25 mL = 25 units on a U-100 scale
• 0.5 mL = 50 units
• 1 mL = 100 units

For example (numbers for illustration only): a 10 mg vial mixed with 2 mL is 5 mg/mL, so a 0.5 mg amount is 0.1 mL, or 10 units, whichever route it’s given by. What differs is the syringe and needle. An insulin syringe’s needle is designed to stop in the fat, so IM injections usually use a separate syringe and a longer needle. Use the units converter to move between mL and units.

Common mistakes

• Choosing a route yourself. It’s part of the prescription.
• Using an insulin syringe for an IM injection. Its short needle is designed to stay in the fat layer.
• Using a long needle for subQ without pinching up the skin, which risks reaching muscle, especially in lean areas.
• Guessing the buttock landmark. Get shown the site in person first.
• Reusing needles, whatever the route.

Questions people ask